Your browser doesn't support javascript.
loading
Integrated environmental, lifestyle, and epigenetic risk prediction of primary gastric neoplasia using the longitudinally monitored cohorts.
Usui, Genki; Matsusaka, Keisuke; Huang, Kie Kyon; Zhu, Feng; Shinozaki, Tomohiro; Fukuyo, Masaki; Rahmutulla, Bahityar; Yogi, Norikazu; Okada, Tomoka; Minami, Mizuki; Seki, Motoaki; Sakai, Eiji; Fujibayashi, Kazutoshi; Kwok Tsao, Stephen Kin; Khor, Christopher; Ang, Tiing Leong; Abe, Hiroyuki; Matsubara, Hisahiro; Fukayama, Masashi; Gunji, Toshiaki; Matsuhashi, Nobuyuki; Morikawa, Teppei; Ushiku, Tetsuo; Yeoh, Khay Guan; Tan, Patrick; Kaneda, Atsushi.
Affiliation
  • Usui G; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Diagnostic Pathology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Matsusaka K; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Pathology, Chiba University Hospital, Chiba, Japan.
  • Huang KK; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.
  • Zhu F; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Shinozaki T; Faculty of Engineering, Department of Information and Computer Technology, Tokyo University of Science, Tokyo, Japan.
  • Fukuyo M; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Rahmutulla B; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Yogi N; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Okada T; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Minami M; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Pathology, Chiba University Hospital, Chiba, Japan.
  • Seki M; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan; Cancer Genomics Center, Chiba University Hospital, Chiba, Japan.
  • Sakai E; Department of Gastroenterology, NTT Medical Center Tokyo, Tokyo, Japan; Division of Gastroenterology, Yokohama Sakae Kyosai Hospital, Yokohama, Japan.
  • Fujibayashi K; Center for Preventive Medicine, NTT Medical Center Tokyo, Tokyo, Japan; Department of General Medicine, Juntendo University Hospital, Tokyo, Japan.
  • Kwok Tsao SK; Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore, Singapore.
  • Khor C; Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Singapore.
  • Ang TL; Department of Gastroenterology and Hepatology, Changi General Hospital, Singapore, Singapore.
  • Abe H; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Matsubara H; Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Fukayama M; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Gunji T; Center for Preventive Medicine, NTT Medical Center Tokyo, Tokyo, Japan.
  • Matsuhashi N; Department of Gastroenterology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Morikawa T; Department of Diagnostic Pathology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Ushiku T; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Yeoh KG; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Department of Gastroenterology and Hepatology, National University Health System, Singapore, Singapore. Electronic address: mdcykg@nus.edu.sg.
  • Tan P; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore; Genome Institute of Singapore, Singapore, Singapore; Cancer Science Institute of Singapore, Singapore, Singapore. Electronic address: gmstanp@duke-nus.edu.sg.
  • Kaneda A; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan; Health and Disease Omics Center, Chiba University, Chiba, Japan. Electronic address: kaneda@chiba-u.jp.
EBioMedicine ; 98: 104844, 2023 Dec.
Article in En | MEDLINE | ID: mdl-38251469
ABSTRACT

BACKGROUND:

DNA methylation accumulates in non-malignant gastric mucosa after exposure to pathogens. To elucidate how environmental, methylation, and lifestyle factors interplay to influence primary gastric neoplasia (GN) risk, we analyzed longitudinally monitored cohorts in Japan and Singapore.

METHODS:

Asymptomatic subjects who underwent a gastric mucosal biopsy on the health check-up were enrolled. We analyzed the association between clinical factors and GN development using Cox hazard models. We further conducted comprehensive methylation analysis on selected tissues, including (i) mucosae from subjects developing GN later, (ii) mucosae from subjects not developing GN later, and (iii) GN tissues and surrounding mucosae. We also use the methylation data of mucosa collected in Singapore. The association between methylation and GN risk, as well as lifestyle and methylation, were analyzed.

FINDINGS:

Among 4234 subjects, GN was developed in 77 subjects. GN incidence was correlated with age, drinking, smoking, and Helicobacter pylori (HP) status. Accumulation of methylation in biopsied gastric mucosae was predictive of higher future GN risk and shorter duration to GN incidence. Whereas methylation levels were associated with HP positivity, lifestyle, and morphological alterations, DNA methylation remained an independent GN risk factor through multivariable analyses. Pro-carcinogenic epigenetic alterations initiated by HP exposure were amplified by unfavorable but modifiable lifestyle choices. Adding DNA methylation to the model with clinical factors improved the predictive ability for the GN risk.

INTERPRETATION:

The integration of environmental, lifestyle, and epigenetic information can provide increased resolution in the stratification of primary GN risk.

FUNDING:

The funds are listed in Acknowledgements section.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: EBioMedicine Year: 2023 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: EBioMedicine Year: 2023 Document type: Article Affiliation country: Japón